SLAMF7 Polyclonal Antibody-BS75615 Biopharmaceutical manufacturing MMP-26 is widely expressed in

MMP-26 is widely expressed in a number of malignant tumor lines where it is thought to play an important role in tissue remodeling events that are associated with carcinogenesis

CR1/CD35 also participates in negative regulation of the complement cascade through its ability to promote dissociation of C3 and C5 convertases and by serving as one of multiple cofactors for Factor-I-mediated cleavage and inactivation of C3b and C4b

Immunogen: A synthetic peptide corresponding to residues in Human FGF4

Trans-interaction with PVR induces activation of CDC42 and RAC small G proteins through common signaling molecules such as SRC and RAP1

GeneID: 7030

SLAMF7 Polyclonal Antibody-BS75615 Biopharmaceutical manufacturing MMP-26 is widely expressed inSLAMF7 Polyclonal Antibody Sizes: 50l, 100l Catalogue Numbers: BS75615 50, BS75615 100 Product: 1mg ml in PBS with 0. 02% sodium azide, 50% glycerol, pH7. 2 Swiss Prot: Q9NQ25 Host: Rabbit Reactivity: Human, Mouse Applications: WB All Applications: WB,1: 500 1: 2000 Background: SLAM family member 7 (SLAMF7), also known as CRACC, CD319, CD2 like receptor activating cytotoxic cells, and CS1, is a single pass type I membrane protein and a member of the